* Further details of differences between Reported and Core are shown in Table 12 ...
Pascal Soriot, Chief Executive Officer, AstraZeneca, said: “Building on our strong growth in the first half of the year and continued underlying demand for our medicines we are upgrading our FY 2024 ...
WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca will showcase new clinical and real-world data across its leading inhaled, biologic and early science respiratory portfolio at the American Thoracic ...
Judging from its top line, AstraZeneca had a stellar 2024, generating an 18% increase in revenue, with 14 of the products in its deep portfolio achieving blockbuster sales. But the British drugmaker ...
We recently compiled a list of the U.K. Dividend Champions List: 2024 Rankings by Yield. In this article, we are going to take a look at where AstraZeneca PLC (NASDAQ:AZN) stands against the other U.K ...
We recently compiled a list of the U.K. Dividend Aristocrats List: 2024 Rankings by Yield. In this article, we are going to take a look at where AstraZeneca PLC (NASDAQ:AZN) stands against the other U ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results